| Vivek S Sahgal, MD, FACP | |
|
1201 Michigan Ave, Suite 170, Logansport, IN 46947-1580 | |
| (574) 722-4331 | |
| (574) 722-6856 |
| Full Name | Vivek S Sahgal |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 39 Years |
| Location | 1201 Michigan Ave, Logansport, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215964127 | NPI | - | NPPES |
| 1215964127 | Other | KS | UNICARE |
| 243233 | Other | KS | COVENTRY |
| 25244031 | Other | MO | BCBSKC |
| P00230613 | Other | KS | MEDICARE RAILROAD |
| 100290230D | Medicaid | KS | |
| 201209650 | Medicaid | IN | |
| 209722024 | Medicaid | MO | |
| 5188509 | Other | KS | AETNA |
| 104950 | Other | KS | MEDICARE LEAVENWORTH INDIVIDUAL |
| 104950 | Other | KS | BCBSKC |
| MA1199001 | Other | MO | MEDICARE |
| 121596412 | Other | MO | MOLINA INDIVIDUAL |
| P01283806 | Other | IN | RAILROAD MEDICARE |
| 000000852931 | Other | IN | ANTHEM |
| Facility Name | Location | Facility Type |
|---|---|---|
| Angels Of Mercy Homecare | Marion, IN | Home health agency |
| Elara Caring | Kokomo, IN | Home health agency |
| Guardian Angel Hospice Inc | Kokomo, IN | Hospice |
| Memorial Hospital | Logansport, IN | Hospital |
| Woodbridge Health Campus | Logansport, IN | Nursing home |
| Miller's Merry Manor | Logansport, IN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hospital | 8123923281 | 73 |
News Archive
Genta Incorporated announced today that the Company has entered into definitive agreements with institutional investors for a private placement of Convertible Notes totaling $25 million in gross proceeds. The transaction is expected to close on or about March 10, 2010, subject to the satisfaction of customary closing conditions.
SORLA is a protein that influences the balance of metabolic processes in adipose tissue, a particular form of fat. Too much of it makes fat cells overly sensitive to insulin, which leads them to break down less fat. SORLA was previously known for its protective role in Alzheimer's disease.
Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).
Novavax, Inc. announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no longer on clinical hold. In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved.
One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques-collectively referred to as synthetic biology-have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes.
› Verified 5 days ago
| Entity Name | Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942317656 PECOS PAC ID: 8123923281 Enrollment ID: O20031206000001 |
News Archive
Genta Incorporated announced today that the Company has entered into definitive agreements with institutional investors for a private placement of Convertible Notes totaling $25 million in gross proceeds. The transaction is expected to close on or about March 10, 2010, subject to the satisfaction of customary closing conditions.
SORLA is a protein that influences the balance of metabolic processes in adipose tissue, a particular form of fat. Too much of it makes fat cells overly sensitive to insulin, which leads them to break down less fat. SORLA was previously known for its protective role in Alzheimer's disease.
Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).
Novavax, Inc. announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no longer on clinical hold. In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved.
One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques-collectively referred to as synthetic biology-have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vivek S Sahgal, MD, FACP 1201 Michigan Ave, Suite 170, Logansport, IN 46947-1580 Ph: (574) 722-4331 | Vivek S Sahgal, MD, FACP 1201 Michigan Ave, Suite 170, Logansport, IN 46947-1580 Ph: (574) 722-4331 |
News Archive
Genta Incorporated announced today that the Company has entered into definitive agreements with institutional investors for a private placement of Convertible Notes totaling $25 million in gross proceeds. The transaction is expected to close on or about March 10, 2010, subject to the satisfaction of customary closing conditions.
SORLA is a protein that influences the balance of metabolic processes in adipose tissue, a particular form of fat. Too much of it makes fat cells overly sensitive to insulin, which leads them to break down less fat. SORLA was previously known for its protective role in Alzheimer's disease.
Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).
Novavax, Inc. announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no longer on clinical hold. In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved.
One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques-collectively referred to as synthetic biology-have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes.
› Verified 5 days ago
Dr. Marc Sheldon Nusholtz, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 Michigan Ave, Logansport, IN 46947 Phone: 574-753-1302 | |
Cherie A Bennett, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 Michigan Ave, Suite 170, Logansport, IN 46947 Phone: 574-722-4331 | |
Mr. Benjamin Thomas Anderson, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 Michigan Ave, Logansport, IN 46947 Phone: 574-753-7541 | |
David L Morrical, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1201 Michigan Ave, Suite 170, Logansport, IN 46947 Phone: 574-722-4331 Fax: 574-722-6856 |